Introduction

Harm reduction is an evidence-based approach that seeks to minimize the negative consequences associated with drug use and other risky behaviors, while promoting the health and well-being of individuals and communities.

In the context of HIV prevention, harm reduction strategies have proven to be effective in reducing the transmission of the virus among people who use drugs (PWUD). Research shows that providing access to sterile needles and syringes, opioid substitution therapy, HIV testing, counseling, and other harm reduction services can significantly decrease the risk of HIV infection.

Moreover, harm reduction programs go beyond the prevention of HIV transmission. They also address the broader health and social needs of PWUD, including Hepatitis C prevention and treatment, overdose prevention, access to healthcare, and harm reduction education.

Session Objectives

• The Role of People Who Use and Inject Drugs (PWU/ID) in Scaling Harm Reduction Programmes
• Bringing programmes closer to the populations they Serve
• Addressing the Needs of PWU/ID in HIV Prevention and Other Services
• Discussing Technical Issues and Key Elements  of Harm Reduction

‍Proceedings‍

• During this session, Daria Matyushina from UNAIDS welcomed the participants and  outlined the objectives of the meeting outlining the session objectives.

• Edem Ekpenyong from Nigerian Network of People who Use Drugs (NNPUD) and Oleg Dumar from VOLNA discussed the essential role of the community in harm reduction programs. They highlighted the     importance of community involvement, support, and grassroots initiatives.
• Monica Ciupagea from UNODC provided a comprehensive global overview of harm reduction programs. She shared insights into the current state of harm     reduction efforts, strategies, and challenges.
• An interactive session was conducted to identify the barriers faced in implementing harm reduction programs. This allowed participants to actively engage and
• Timothy  Kilonzo from Kenya and Tetiana Deshko from Ukraine presented practical  approaches to implementing harm reduction programs at a larger scale. They     shared their experiences, strategies, and successful initiatives.
• Susie  McLean from The Global Fund, along with Ansley Lyn from PEPFAR/CDC, reflected on the discussions and made commitments towards advancing harm     reduction efforts. They emphasized the importance of collaboration, funding, and ongoing support.    
• Daria Matyushina from UNAIDS concluded the session, summarizing the key points discussed and highlighting the significance of continued efforts in harm     reduction programs.

Event resources

The recording and presentation from this session can be accessed below. Remember sharing with your network is a great way to make a difference!